|
[1]
|
Nichols, M., Townsend, N., Scarborough, P. and Rayner, M. (2014) Cardiovascular Disease in Europe 2014: Epidemiological Update. European Heart Journal, 35, 2950-2959. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Bobryshev, Y.V., Ivano-va, E.A., Chistiakov, D.A., et al. (2016) Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis. BioMed Research International, 2016, Article ID: 9582430. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Libby, P. (2002) Inflammation in Atherosclerosis. Nature, 420, 868-874. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, Y., Liu, S., Wu, L., Liu, Y., Du, J., Luo, Z., et al. (2023) Epigenetic Reg-ulation of Chemokine (CC-Motif) Ligand 2 in Inflammatory Diseases. Cell Proliferation, 56, e13428. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pekayvaz, K., Gold, C., Hoseinpour, P., Engel, A., Martinez-Navarro, A., Eivers, L., et al. (2023) Mural Cell-Derived Chemokines Provide a Protective Niche to Safeguard Vascular Macrophages and Limit Chronic Inflammation. Immunity, 56, 2325-2341.e15. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ross, R. (1999) Atherosclerosis—An Inflammatory Disease. The New England Journal of Medicine, 340, 115-126. [Google Scholar] [CrossRef]
|
|
[7]
|
Gordon, S. (1995) The Macrophage. Bioessays, 17, 977-986. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Murai, K.K. and Pasquale, E.B. (2003) ‘Eph’ective Signaling: Forward, Re-verse and Crosstalk. Journal of Cell Science, 116, 2823-2832. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Palmer, A. and Klein, R. (2003) Multiple Roles of Ephrins in Morphogenesis, Neuronal Networking, and Brain Function. Genes & Development, 17, 1429-1450. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sakamoto, A., Ishibashi-Ueda, H., Sugamoto, Y., Higashikata, T., Miyamoto, S., Kawashiri, M.-A., et al. (2008) Expression and Function of Ephrin-B1 and Its Cognate Receptor EphB2 in Hu-man Atherosclerosis: From an Aspect of Chemotaxis. Clinical Science (London), 114, 643-650. [Google Scholar] [CrossRef]
|
|
[11]
|
Ende, G., Poitz, D.M., Wiedemann, E., Augstein, A., Friedrichs, J., Giebe, S., et al. (2014) TNF-α-Mediated Adhesion of Monocytes to Endothelial Cells—The Role of EphrinA1. Journal of Molecular and Cellular Cardiology, 77, 125-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Finney, A.C., Funk, S.D., Green, J.M., Yurdagul, A., Rana, M.A., Pis-torius, R., et al. (2017) EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis. Cir-culation, 136, 566-582. [Google Scholar] [CrossRef]
|
|
[13]
|
Sakamoto, A., Sugamoto, Y., Tokunaga, Y., Yoshimuta, T., Hayashi, K., Konno, T., et al. (2011) Expression Profiling of the Ephrin (EFN) and Eph Receptor (EPH) Family of Genes in Atherosclerosis-Related Human Cells. Journal of International Medical Research, 39, 522-527. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
van Gils, J.M., Ramkhelawon, B., Fernandes, L., Stewart, M.C., et al. (2013) Endothelial Expression of Guidance Cues in Vessel Wall Homeostasis Dysregulation under Proatherosclerotic Condi-tions. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 911-919. [Google Scholar] [CrossRef]
|
|
[15]
|
Welch, C.L., Bretschger, S., Latib, N., Bezouevski, M., Guo, Y., Pleskac, N., et al. (2001) Localization of Atherosclerosis Susceptibility Loci to Chromosomes 4 and 6 Using the Ldlr Knockout Mouse Model. Proceedings of the National Academy of Sciences, 98, 7946-7951. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Vreeken, D., Bruikman, C.S., Cox, S.M.L., Zhang, H., Lalai, R., Koudijs, A., et al. (2020) EPH Receptor B2 Stimulates Human Monocyte Adhesion and Migration Independently of Its EphrinB Ligands. Journal of Leukocyte Biology, 108, 999-1011. [Google Scholar] [CrossRef]
|
|
[17]
|
Himanen, J.-P., Saha, N. and Nikolov, D.B. (2007) Cell-Cell Signaling via Eph Receptors and Ephrins. Current Opinion in Cell Biology, 19, 534-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ivanov, A.I. and Romanovsky, A.A. (2006) Putative Dual Role of Ephrin-Eph Receptor Interactions in Inflammation. IUBMB Life, 58, 389-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Kalo, M.S. and Pasquale, E.B. (1999) Signal Transfer by Eph Recep-tors. Cell and Tissue Research, 298, 1-9. [Google Scholar] [CrossRef]
|
|
[20]
|
Kullander, K. and Klein, R. (2002) Mechanisms and Functions of Eph and Ephrin Signalling. Nature Reviews Molecular Cell Biology, 3, 475-486. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Pasquale, E.B. (2005) Eph Receptor Signalling Casts a Wide Net on Cell Behaviour. Nature Reviews Molecular Cell Biology, 6, 462-475. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., et al. (2009) EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Recip-rocal Regulatory Loop with Akt. Cancer Cell, 16, 9-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Barquilla, A., Lamberto, I., Noberini, R., Heynen-Genel, S., Brill, L.M. and Pasquale, E.B. (2016) Protein Kinase A Can Block EphA2 Re-ceptor-Mediated Cell Repulsion by Increasing EphA2 S897 Phosphorylation. Molecular Biology of the Cell, 27, 2757-2770. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Miao, H., Gale, N.W., Guo, H., Qian, J., Petty, A., Kaspar, J., et al. (2015) EphA2 Promotes Infiltrative Invasion of Glioma Stem Cells in Vivo through Cross-Talk with Akt and Regulates Stem Cell Properties. Oncogene, 34, 558-567. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Strong, T.A., Esquivel, J., Wang, Q., Ledon, P.J., Wang, H., Gaidosh, G., et al. (2023) Activation of Multiple Eph Receptors on Neuronal Membranes Correlates with the Onset of Optic Neuropathy. Eye and Vision (London), 10, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Li, W., Wen, L., Rathod, B., Gingras, A.C., Ley, K. and Lee, H.-S. (2023) Kindlin2 Enables EphB/EphrinB Bi-Directional Signaling to Support Vascular Development. Life Science Alliance, 6, 1-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Papadakos, S.P., Dedes, N., Gkolemi, N., Machairas, N. and Theocharis, S. (2023) The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences, 24, Article 3015. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Arora, S., Scott, A.M. and Janes, P.W. (2023) Eph Receptors in Cancer. Bio-medicines, 11, 1-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Funk, S.D., Yurdagul, A., Albert, P., Traylor, J.G., Jin, L., Chen, J. and Orr, A.W. (2012) EphA2 Activation Promotes the Endothelial Cell Inflammatory Response: A Potential Role in Athero-sclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 686-695. [Google Scholar] [CrossRef]
|
|
[30]
|
Jiang, H., Li, X., Zhang, X., Liu, Y., Huang, S. and Wang, X. (2014) EphA2 Knockdown Attenuates Atherosclerotic Lesion Development in ApoE-/- Mice. Cardiovascular Pathology, 23, 169-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Braun, J., Hoffmann, S.C., Feldner, A., Ludwig, T., Henning, R., Hecker, M. and Korff, T. (2011) Endothelial Cell EphrinB2-Dependent Activation of Monocytes in Arteriosclerosis. Arterio-sclerosis, Thrombosis, and Vascular Biology, 31, 297-305. [Google Scholar] [CrossRef]
|
|
[32]
|
Brantley-Sieders, D.M. and Chen, J. (2004) Eph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease. Angiogenesis, 7, 17-28. [Google Scholar] [CrossRef]
|
|
[33]
|
Mitra, S., Goyal, T. and Mehta, J.L. (2011) Oxidized LDL, LOX-1 and Atherosclerosis. Cardiovascular Drugs and Therapy, 25, 419-429. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Tedgui, A. and Mallat, Z. (2006) Cytokines in Atherosclerosis: Patho-genic and Regulatory Pathways. Physiological Reviews, 86, 515-581. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Werner, S.L., Kearns, J.D., Zadorozhnaya, V., Lynch, C., et al. (2008) Encoding NF-kappaB Temporal Control in Response to TNF: Distinct Roles for the Negative Regulators IkappaBalpha and A20. Genes & Development, 22, 2093-2101. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Hehlgans, T. and Pfeffer, K. (2005) The Intriguing Biology of the Tumour Ne-crosis Factor/Tumournecrosis Factor Receptor Superfamily: Players, Rules and the Games. Immunology, 115, 1-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Old, L.J. (1985) Tumor Necrosis Factor (TNF). Science, 230, 630-632. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Collins, T., Read, M.A., Neish, A.S., Whitley, M.Z., Thanos, D. and Maniatis, T. (1995) Transcriptional Regulation of Endothelial Cell Adhesion Molecules: NF-kappaB and Cytokine-Inducible Enhancers. FASEB Journal, 9, 899-909. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Baeuerle, P.A. and Henkel, T. (1994) Function and Activation of NF-kappaB in the Immune System. Annual Review of Immunology, 12, 141-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Sharfe, N., Nikolic, M., Cimpeon, L., van de Kratts, A., Frey-wald, A. and Roifman, C.M. (2008) EphA and Ephrin-A Proteins Regulate Integrin-Mediated T Lymphocyte Interactions. Mo-lecular Immunology, 45, 1208-1220. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Cheng, N., Brantley, D.M., Liu, H., et al. (2002) Blockade of EphA Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-Induced Angiogenesis. Molecular Can-cer Research, 1, 2-11.
|
|
[42]
|
Moulton, K.S., Vakili, K., Zurakowski, D., et al. (2003) Inhibition of Plaque Neovascularization Reduces Macrophage Accumulation and Progression of Advanced Atherosclerosis. Proceedings of the National Academy of Sciences, 100, 4736-4741. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Moulton, K.S., Heller, E., Konerding, M.A., Flynn, E., Palinski, W. and Folkman, J. (1999) Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovasculariza-tion and Plaque Growth in Apolipoprotein E-Deficient Mice. Circulation, 99, 1726-1732. [Google Scholar] [CrossRef]
|
|
[44]
|
Osterud, B. and Bjorklid, E. (2003) Role of Monocytes in Atherogenesis. Physiological Reviews, 83, 1069-1112. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Imhof, B.A. and Aurrand-Lions, M. (2004) Adhesion Mechanisms Regulating the Migration of Monocytes. Nature Reviews Immunology, 4, 432-444. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Lucas, A.D. and Greaves, D.R. (2001) Atherosclerosis: Role of Chemokines and Macrophages. Expert Reviews in Molecular Medicine, 3, 1-18. [Google Scholar] [CrossRef]
|
|
[47]
|
Wu, J. and Luo, H. (2005) Recent Advances on T-Cell Regulation by Receptor Tyrosine Kinases. Current Opinion in Hematology, 12, 292-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Davignon, J. and Ganz, P. (2004) Role of Endotheli-al Dysfunction in Atherosclerosis. Circulation, 109, III27-III32. [Google Scholar] [CrossRef]
|
|
[49]
|
Terkeltaub, R., Boisvert, W.A. and Curtiss, L.K. (1998) Chemokines and Atherosclerosis. Current Opinion in Lipidology, 9, 397-405. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Apostolopoulos, J., Davenport, P. and Tipping, P.G. (1996) Interleukin-8 Production by Macrophages from Atheromatous Plaques. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 1007-1012. [Google Scholar] [CrossRef]
|
|
[51]
|
Wang, N., Tabas, I., Winchester, R., et al. (1996) Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma. Journal of Biological Chemistry, 271, 8837-8842. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Ribeiro, R.A., Flores, C.A., Cunha, F.Q. and Ferreira, S.H. (1991) IL-8 Causes in Vivo Neutrophil Migration by a Cell-Dependent Mechanism. Immunology, 73, 472-477.
|
|
[53]
|
Gerszten, R.E., Gar-cia-Zepeda, E.A., Lim, Y.C., Yoshida, M., Ding, H.A., Gimbrone, M.A., et al. (1999) MCP-1 and IL-8 Trigger firm Adhesion of Monocytes to Vascular Endothelium under Flow Conditions. Nature, 398, 718-723. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Suzuki, Y., Yamamoto, K., Ando, J., Matsumoto, K. and Matsuda, T. (2012) Arterial Shear Stress Augments the Differentiation of Endothelial Progenitor Cells Adhered to VEGF-Bound Surfaces. Biochemical and Biophysical Research Communications, 423, 91-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Himanen, J.-P. and Nikolov, D.B. (2003) Eph Signaling: A Structural View. Trends in Neurosciences, 26, 46-51. [Google Scholar] [CrossRef]
|
|
[56]
|
Füller, T., Korff, T., Kilian, A., Dandekar, G. and Augustin, H.G. (2003) Forward EphB4 Signaling in Endothelial Cells Controls Cellular Repulsion and Segregation from EphrinB2 Positive Cells. Journal of Cell Science, 116, 2461-2470. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Poitz, D.M., Ende, G., Stütz, B., Augstein, A., Friedrichs, J., Brunssen, C., et al. (2015) EphrinB2/EphA4-Mediated Activation of Endothelial Cells Increases Monocyte Adhesion. Molecular Immunology, 68, 648-656. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Mestas, J. and Ley, K. (2008) Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis. Trends in Cardiovascular Medicine, 18, 228-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Dawes, A.T. and Edelstein-Keshet, L. (2007) Phosphoinositides and Rho Proteins Spatially Regulate Actin Polymerization to Initiate and Maintain Directed Movement in a One-Dimensional Model of a Motile Cell. Biophysical Journal, 92, 744-768. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Pasquale, E.B. (2008) Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell, 133, 38-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Zamora, D.O., Babra, B., Pan, Y., Planck, S.R. and Rosenbaum, J.T. (2006) Human Leukocytes Express EphrinB2 Which Activates Microvascular Endothelial Cells. Cellular Immunology, 242, 99-109. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Chan, B. and Sukhatme, V.P. (2009) Receptor Tyrosine Kinase EphA2 Mediates Thrombin-Induced Upregulation of ICAM-1 in Endothelial Cells in Vitro. Thrombosis Research, 123, 745-752. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Carpenter, T.C., Schroeder, W., Stenmark, K.R. and Schmidt, E.P. (2012) Eph-A2 Promotes Permeability and Inflammatory Responses to Bleomycin-Induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology, 46, 40-47. [Google Scholar] [CrossRef]
|
|
[64]
|
Veeranna, V., Zala-wadiya, S.K., Niraj, A., Pradhan, J., et al. (2011) Homocysteine and Reclassification of Cardiovascular Disease Risk. Journal of the American College of Cardiology, 58, 1025-1033. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Lai, W.K.C. and Kan, M.Y. (2015) Homocysteine-Induced Endothelial Dysfunction. Annals of Nutrition and Metabolism, 67, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Kojima, Y., Ono, K., Inoue, K., Takagi, Y., Kikuta, K., Nishimura, M., et al. (2009) Progranulin Expression in Advanced Human Atherosclerotic Plaque. Atherosclerosis, 206, 102-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Kawase, R., Ohama, T., Matsuyama, A., Matsuwaki, T., Okada, T., Yamashita, T., et al. (2013) Deletion of Progranulin Exacerbates Atherosclerosis in ApoE Knockout Mice. Cardiovascular Research, 100, 125-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Vincent, P.A., Xiao, K., Buckley, K.M. and Kowalczyk, A.P. (2004) VE-Cadherin: Adhesion at Arm’s Length. American Journal of Physiology-Cell Physiology, 286, C987-C997. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Tian, D., Qin, Q., Li, M., Li, X., Xu, Q. and Lv, Q. (2020) Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway. Frontiers in Pharma-cology, 11, Article 614760. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Neill, T., Buraschi, S., Goyal, A., Sharpe, C., Natkanski, E., Schaefer, L., Morrione, A. and Iozzo, R.V. (2016) EphA2 Is a Functional Receptor for the Growth Factor Progranulin. Journal of Cell Biol-ogy, 215, 687-703. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Sharfe, N., Freywald, A., Toro, A., Dadi, H. and Roifman, C. (2002) Ephrin Stimulation Modulates T Cell Chemotaxis. European Journal of Immunology, 32, 3745-3755. [Google Scholar] [CrossRef]
|
|
[72]
|
Kitamura, T., Kabuyama, Y., Kamataki, A., Homma, M.K., Kobayashi, H., Aota, S., et al. (2008) Enhancement of Lymphocyte Migration and Cytokine Production by EphrinB1 System in Rheumatoid Arthritis. American Journal of Physiology-Cell Physiology, 294, C189-C196. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Boyd, A.W., Bartlett, P.F. and Lackmann, M. (2014) Therapeutic Target-ing of EPH Receptors and Their Ligands. Nature Reviews Drug Discovery, 13, 39-62. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Lennon, S., Oweida, A., Milner, D., Phan, A.V., Bhatia, S., van Court, B., et al. (2019) Pancreatic Tumor Microenvironment Modulation by EphB4-EphrinB2 Inhibition and Radiation Combination. Clinical Cancer Research, 25, 3352-3365. [Google Scholar] [CrossRef]
|